Exosomes released by mesenchymal stem cells may help reduce vascular remodeling and ease PH symptoms, a rat study showed.

An annual art challenge takes some interesting twists and turns for columnist Anna Jeter, who's honoring her renewed health.

An agreement on L606, a slow-release formulation of inhaled treprostinil now in a Phase 3 trial, was extended by Pharmosa and ...

The use of selenium supplements was found to reduce blood vessel remodeling, a hallmark of pulmonary arterial hypertension, ...

The investigational therapy CS1 led to beneficial changes in for people with pulmonary arterial hypertension in a Phase 2a ...

Living with a rare or chronic disease is never easy, as it creates many emotional, financial, physical, and social challenges. One difficult aspect is learning that a particular condition has ...

Most adults with pulmonary arterial hypertension (PAH) who switched to Uptravi (selexipag) from other medications in its class achieved stabilization or a lessening of disease severity, according to ...

Cereno Scientific’s investigational therapy CS014 was found to reverse remodeling, meaning alterations in structure and arrangement, of pulmonary arteries in a preclinical model of pulmonary arterial ...